The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quigg, R. J.
Right arrow Articles by Sneed, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quigg, R. J.
Right arrow Articles by Sneed, A. E., 3rd

The Journal of Immunology, Vol 154, Issue 7 3437-3443, Copyright © 1995 by American Association of Immunologists

ARTICLES

Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis

RJ Quigg, VM Holers, BP Morgan and AE Sneed 3rd
Department of Medicine, University of Chicago, IL 60637.

Human glomerular epithelial cells (GEC) contain CD59, decay- accelerating factor, and membrane cofactor protein. Crry is the rodent analogue to the latter two proteins. We have previously shown that the nephritogenic Ab of passive Heymann nephritis, anti-Fx1A, impairs C regulation in rat GEC. Here we examined rat GEC C regulation. 125I- labeled GEC membrane proteins were immunoprecipitated with anti-Crry, anti-CD59, or anti-Fx1A. Crry and CD59 were present in GEC. Anti-Fx1A reacted with both Crry and CD59 from GEC, as well as with purified rCrry and CD59. The alternative C pathway was studied by incubating GEC in rat serum in Mg(++)-EGTA buffer. To inhibit the function of the C regulators, anti-Crry or anti-CD59 Ab were added to GEC. Inhibition of CD59 function alone had no effect on C regulation, whereas inhibition of Crry led to significant cytotoxicity from alternative pathway activation. Under conditions in which Crry was inactive, inhibition of CD59 further enhanced cytotoxicity. When the classical pathway of C was activated by GEC-bound IgG Ab, inhibition of either Crry or CD59 enhanced cytotoxicity, whereas inhibition of both Crry and CD59 together was additive. Therefore, Crry and CD59 are present and functionally active in GEC. Crry restricts C activation via both alternative and classical pathways. When the classical pathway of C is activated, or when Crry function is inhibited, CD59 limits C5b-9- mediated cytotoxicity. Anti-Fx1A binds to both Crry and CD59, which may account for its ability to activate the alternative pathway in vitro, and for its superior nephritogenicity in vivo.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
A. V. Cybulsky, R. J. Quigg, and D. J. Salant
Experimental membranous nephropathy redux
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F660 - F671.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. N. Cunningham and R. J. Quigg
Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1214 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Turnberg, M. Botto, J. Warren, B. P. Morgan, Mark. J. Walport, and H. T. Cook
CD59a Deficiency Exacerbates Accelerated Nephrotoxic Nephritis in Mice
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2271 - 2279.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
H. Pavenstadt, W. Kriz, and M. Kretzler
Cell Biology of the Glomerular Podocyte
Physiol Rev, January 1, 2003; 83(1): 253 - 307.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Ren, M. Doshi, B. K. Hack, J. J. Alexander, and R. J. Quigg
Isolation and Characterization of a Novel Rat Factor H-related Protein That Is Up-regulated in Glomeruli under Complement Attack
J. Biol. Chem., December 6, 2002; 277(50): 48351 - 48358.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. J. Alexander, A. K. Saxena, L. Bao, A. Jacob, M. Haas, and R. J. Quigg
Prominent Renal Expression of a Murine Leukemia Retrovirus in Experimental Systemic Lupus Erythematosus
J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2869 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Sekine, C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson
Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice
J. Immunol., May 15, 2001; 166(10): 6444 - 6451.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. McGrath, G. W. G. Wilkinson, O. B. Spiller, and B. P. Morgan
Development of Adenovirus Vectors Encoding Rat Complement Regulators for Use in Therapy in Rodent Models of Inflammatory Diseases
J. Immunol., December 15, 1999; 163(12): 6834 - 6840.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
R. J. Quigg, C. He, A. Lim, D. Berthiaume, J. J. Alexander, D. Kraus, and V. Michael Holers
Transgenic Mice Overexpressing the Complement Inhibitor Crry as a Soluble Protein Are Protected from Antibody-induced Glomerular Injury
J. Exp. Med., October 5, 1998; 188(7): 1321 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
B. Schiller, C. He, D. J. Salant, A. Lim, J. J. Alexander, and R. J. Quigg
Inhibition of Complement Regulation Is Key to the Pathogenesis of Active Heymann Nephritis
J. Exp. Med., October 5, 1998; 188(7): 1353 - 1358.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
T. E. Mollnes and M. Harboe
Recent Advances: Clinical immunology
BMJ, June 8, 1996; 312(7044): 1465 - 1469.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.